Jonas Dyhrfjeld-Johnsen

Jonas Dyhrfjeld-Johnsen

Company: Acousia Therapeutics

Job title: Chief Development Officer & Managing Director

Seminars:

Accelerating Small Molecule Therapies to Drive Clinical Advancement in Inner Ear Therapeutics 12:15 pm

Exploring the achievements of initial clinical trials and outlining strategic approaches to sustain and build upon this success in later stages Evaluating ongoing Phase II studies and interpreting their findings to inform future development and clinical strategies How to plan for further clinical development, with patient enrolment in mind Read more

day: Day 1

Industry Leaders Fireside Chat: Exploring the Highlights & Hurdles from the Past Year to Inform Your 2025 Strategy 9:00 am

An executive panel discussion from industry leaders of the field to set the scene on the inner ear disorders therapy space. Ask your questions live to understand the expert’s thoughts on key topics including: Highlighting and celebrating the big wins for inner ear therapeutics in the last year Considering the challenges facing inner ear research…Read more

day: Day 1

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.